Health
PET/CT insights predict immunotherapy response in patients with advanced lung cancer – Health Imaging
Checkpoint inhibitors target the PD-L1/PD1 signaling pathway and are commonly used to treat those with NSCLC. While this therapy can be highly effective, it only works for nearly 50% of patients.
In order to avoid treating those who likely wont respond,…
Continue Reading
-
Noosa News21 hours agoCommissioner thanks police officer who threw a speed radar at a car
-
Noosa News19 hours agoNo matter what happens in his Origin debut, history beckons for rookie maroon Robert Toia
-
Noosa News20 hours agoDefence investigation finds Taipan pilot’s actions possibly prevented further fatalities in crash
-
General17 hours agoDairy farmers devastated by floods across parts of New South Wales